FFM
BHVN

Fairmount Funds Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Fairmount Funds Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-204,743
Closed -$31M – 27
2022
Q3 		$31M Sell
204,743
-59,463
-23% -$8.99M 5.44% 5
2022
Q2 		$38.5M Buy
264,206
+24,892
+10% +$3.63M 8.81% 1
2022
Q1 		$28.4M Buy
239,314
+183,667
+330% +$21.8M 6.71% 6
2021
Q4 		$7.67M Buy
+55,647
New +$7.67M 2.53% 15